| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.5M | -2.1% | +7.1% |
| Cost of Revenue | $6.0M | -2.9% | -10.8% |
| Gross Profit | $16.5M | -1.8% | +15.5% |
| R&D Expense | $7.6M | +4.0% | +0.7% |
| SG&A Expense | $2.3M | -1.0% | +12.1% |
| Operating Income | $2.0M | -1.9% | +7337.0% |
| Pre-tax Income | $2.8M | +5.6% | +770.9% |
| Income Tax | $371K | +22.8% | +46.1% |
| Net Income | $2.4M | +3.4% | +3560.6% |
| EPS (Basic) | $0.09 | +0.0% | — |
| EPS (Diluted) | $0.09 | +12.5% | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $80.5M | -3.1% | +17.1% |
| Accounts Receivable | $8.7M | -36.7% | -29.9% |
| Current Assets | $93.1M | -6.9% | +8.6% |
| Total Assets | $139.7M | -4.8% | +31.5% |
| Current Liabilities | $43.3M | -17.9% | -12.9% |
| Total Liabilities | $48.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $18.7M | — | — |
| Capital Expenditures | $522K | — | — |
| Investing Cash Flow | -$522K | — | — |
| Financing Cash Flow | $1.3M | — | — |
| Free Cash Flow | $18.2M | — | — |
| -11.9% |
| Stockholders' Equity | $91.6M | +3.1% | +77.5% |